Showing results (1-10 of 37) with videos related to

Sort By:
Pageof 4
Bulletin Du Cancer|February 4, 2018
[Funding of anticancer drugs in France]Dominique Levêque
The Lancet. Oncology|November 18, 2008
Off-label use of anticancer drugsDominique Levêque
Bulletin Du Cancer|February 3, 2016
[Biosimilar drugs in oncology]Dominique Levêque
Bulletin Du Cancer|June 30, 2012
[Anticancer agents: has the maximal tolerated price been reached?]Dominique Levêque
Expert Opinion on Drug Safety|October 16, 2025
The importance and utility of post market drug safety monitoring in cancer therapyDominique Levêque
Pharmaceuticals (Basel, Switzerland)|June 27, 2025
Improving the Dosing Schedules of Targeted Anticancer AgentsDominique Levêque
World Journal of Clinical Oncology|April 16, 2016
Off-label use of targeted therapies in oncologyDominique Levêque
Bulletin Du Cancer|August 29, 2007
[Use of body weight and body surface area in dosing of anticancer agents in adult patients]Dominique Levêque
Anticancer Research|November 27, 2008
Evaluation of fixed dosing of new anticancer agents in phase I studiesDominique Levêque
Current Clinical Pharmacology|June 9, 2009
Molecular determinants of fluoroquinolone antibacterial agents pharmacokineticsDominique Levêque, François Jehl
Pageof 4